[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-287297-105":53,"doc-detail-287297-en":127},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":120,"head_meta":122,"extra_data":124,"updated_unix":126},105,"en","consent-letter-citigroup-global-markets-limited-gsk-plc-demerger","Consent Letter - Citigroup Global Markets Limited - GSK plc Demerger","","This formal consent letter issued by Citigroup Global Markets Limited on 1 June 2022 addresses the proposed demerger of Haleon plc by GSK plc. The document explicitly authorizes the inclusion of Citigroup's name and related references within the circular prepared by GSK plc regarding this Class 1 Transaction under FCA Listing Rules. Furthermore, it confirms that Citigroup has provided and not withdrawn this consent, and it designates the letter as available for public inspection, while specifying it is for information purposes only.",{"@graph":63,"@context":119},[64,80,102],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":41,"@type":70,"position":76},"https://docshare.wps.com/template/letters/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/consent-letter-citigroup-global-markets-limited-gsk-plc-demerger/287297/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/consent-letter-citigroup-global-markets-limited-gsk-plc-demerger/287297.png","ImageObject",442,249,{"name":88,"@type":89},"Alex Sinclair","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-09-27","2026-09-17",true,{"@type":98,"interactionType":99,"userInteractionCount":101},"InteractionCounter",{"@type":100},"ViewAction",8,{"@type":103,"mainEntity":104},"FAQPage",[105,111,115],{"name":106,"@type":107,"acceptedAnswer":108},"What is the primary purpose of this document?","Question",{"text":109,"@type":110},"The document serves as a formal consent letter from Citigroup Global Markets Limited to allow the inclusion of its name in the circular concerning the demerger of Haleon plc by GSK plc.","Answer",{"name":112,"@type":107,"acceptedAnswer":113},"To which transaction does this consent apply?",{"text":114,"@type":110},"The consent pertains to the proposed demerger of Haleon plc by GSK plc, which is classified as a Class 1 Transaction under the FCA Listing Rules.",{"name":116,"@type":107,"acceptedAnswer":117},"Is this letter intended for public reliance?",{"text":118,"@type":110},"The letter states it is for the board's information only and should not be relied upon by any other person, though it is made available for inspection.","https://schema.org",{"og:url":78,"og:type":121,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":123,"canonical":78},"index,follow",{"doc_id":125,"site_id":56},287297,1790438962,{"code":4,"msg":5,"data":128},{"doc_id":125,"user_id":129,"nickname":88,"user_avatar":130,"doc_module":9,"category_id":40,"category_name":41,"doc_title":59,"doc_description":61,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":101,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":4},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Citigroup Centre 33 Canada Square Canary Wharf London E14 5LB  \nT +44 (0)20 7986 4000 F +44 (0)20 7986 2266  \nCONSENT LETTER  \nTo: The Board of Directors  \nGSK plc  \n980 Great West Road  \nBrentford  \nMiddlesex  \nTW8 9GS  \n1 June 2022  \nGSK plc (the \"Company\") proposed demerger of Haleon plc, which qualifies as a Class 1 Transaction for the purposes of the Listing Rules of the FCA (the \"Transaction\")  \nWe refer to the circular dated 1 June 2022 and prepared by the Company in connection with the Transaction (the \"Circular\") .  \nWe hereby consent to the inclusion in the Circular of our name and references to it in the form and context in which it appears. We confirm that we have given and have not withdrawn our consent to the inclusion in the Circular of our name in the form and context in which it appears.  \nWe hereby also consent to this letter being made available for inspection. This letter is for your information only and should not be relied upon by any other person.  \nYours faithfully,  \nFor and on behalf of  \nCitigroup Global Markets Limited","cbCaia2OxmM8JGh3","https://ap.wps.com/l/cbCaia2OxmM8JGh3","pdf",112733,"English","# Consent for Inclusion of Name\n## Terms of Disclosure and Inspection","[{\"question\":\"What is the primary purpose of this document?\",\"answer\":\"The document serves as a formal consent letter from Citigroup Global Markets Limited to allow the inclusion of its name in the circular concerning the demerger of Haleon plc by GSK plc.\"},{\"question\":\"To which transaction does this consent apply?\",\"answer\":\"The consent pertains to the proposed demerger of Haleon plc by GSK plc, which is classified as a Class 1 Transaction under the FCA Listing Rules.\"},{\"question\":\"Is this letter intended for public reliance?\",\"answer\":\"The letter states it is for the board's information only and should not be relied upon by any other person, though it is made available for inspection.\"}]","Consent Letter - Citigroup Global Markets Limited - GSK plc Demerger | PDF",1789632125]